Buscar
Bio-Techne Corp
TECHAñadir a la lista de seguimiento
72.195USD
+0.075+0.10%
Horarios del mercado 09/14, 14:35（ET）
11.27BCap. mercado
102.30P/E TTM
Más Datos de Bio-Techne Corp Compañía
Bio-Techne Corporation develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide. The Company’s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, advanced tissue-based in-situ hybridization assays and instrumentation for spatial genomic and tissue biopsy analysis and genetic and oncology kits for research and clinical applications. Its product portfolio and application enable scientific investigations into biological processes and molecular diagnostics and progression of specific diseases.
Perfil de Bio-Techne Corp
Símbolo de cotizaciónTECH
Nombre de la empresaBio-Techne Corp
Fecha de salida a bolsaFeb 09, 1989
Director ejecutivoKelderman (Kim)
Número de empleados3100
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 09
Dirección614 Mckinley Pl N E
CiudadMINNEAPOLIS
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal55413
Teléfono16123798854
Sitio Webhttps://www.bio-techne.com/
Símbolo de cotizaciónTECH
Fecha de salida a bolsaFeb 09, 1989
Director ejecutivoKelderman (Kim)
Ejecutivos de Bio-Techne Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Kim Kelderman
Mr. Kim Kelderman
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
104.23K
+30.82%
Mr. Kim Kelderman
Mr. Kim Kelderman
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
104.23K
+30.82%
Mr. John L. Higgins
Mr. John L. Higgins
Independent Director
Independent Director
66.88K
--
Mr. John L. Higgins
Mr. John L. Higgins
Independent Director
Independent Director
66.88K
--
Mr. Robert V. (Bob) Baumgartner, CPA
Mr. Robert V. (Bob) Baumgartner, CPA
Independent Chairman of the Board
Independent Chairman of the Board
46.50K
--
Mr. Robert V. (Bob) Baumgartner, CPA
Mr. Robert V. (Bob) Baumgartner, CPA
Independent Chairman of the Board
Independent Chairman of the Board
46.50K
--
Dr. Joseph D. (Joe) Keegan, Ph.D.
Dr. Joseph D. (Joe) Keegan, Ph.D.
Independent Director
Independent Director
15.41K
--
Dr. Joseph D. (Joe) Keegan, Ph.D.
Dr. Joseph D. (Joe) Keegan, Ph.D.
Independent Director
Independent Director
15.41K
--
Mr. Shane Bohnen
Mr. Shane Bohnen
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
14.71K
+50.02%
Mr. Shane Bohnen
Mr. Shane Bohnen
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
14.71K
+50.02%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Kim Kelderman
Mr. Kim Kelderman
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
104.23K
+30.82%
Mr. Kim Kelderman
Mr. Kim Kelderman
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
104.23K
+30.82%
Mr. John L. Higgins
Mr. John L. Higgins
Independent Director
Independent Director
66.88K
--
Mr. John L. Higgins
Mr. John L. Higgins
Independent Director
Independent Director
66.88K
--
Mr. Robert V. (Bob) Baumgartner, CPA
Mr. Robert V. (Bob) Baumgartner, CPA
Independent Chairman of the Board
Independent Chairman of the Board
46.50K
--
Mr. Robert V. (Bob) Baumgartner, CPA
Mr. Robert V. (Bob) Baumgartner, CPA
Independent Chairman of the Board
Independent Chairman of the Board
46.50K
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Bio-Techne Corp?
Los cinco principales accionistas de Bio-Techne Corp son: Mr. Kim Kelderman
¿Cuántas instituciones poseen acciones de Bio-Techne Corp (TECH)?
A fecha de 2026Q1, 1247 instituciones poseen acciones de Bio-Techne Corp, con un valor de mercado combinado de aproximadamente 178.19M, lo que representa el 113.81% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 1433.00.
¿Cuál es la mayor fuente de ganancias de Bio-Techne Corp?
El 2026Q1, el segmento empresarial Consumables generó la ganancia más alta para Bio-Techne Corp, ascendiendo a 985.12M y representando el 81.08% de la ganancia total.